GlassScriptPhysician profile
Kurt D Edwards
NPI 1033184916
$796.72
in general payments reported to CMS, 2019-2025
12 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $11.92 · 2023: $147 · 2024: $312 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.68 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $184.86 | 2024-2025 | V.A.C. Granufoam, Abthera, Prevena |
| Ethicon US, LLC | $163.95 | 2023-2024 | Dermabond, Vistaseal, Stratafix |
| Allergan, INC. | $125.12 | 2019 | |
| Abiomed | $92.33 | 2023-2024 | Impella |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $82.62 | 2024-2025 | |
| Haemonetics Corporation | $49.74 | 2025 | Teg6s Hemostasis System, Teg5000 Hemostasis Analyzer |
| Edwards Lifesciences Corporation | $22.95 | 2023 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Davol INC. | $19.44 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $13.99 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acell, INC. | $11.92 | 2020 | |
| Intuitive Surgical, INC. | $9.80 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.